RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보 SCOPUS SCIE

      Growth Inhibitory Effect of Palatine Tonsil-derived Mesenchymal Stem Cells on Head and Neck Squamous Cell Carcinoma Cells

      한글로보기

      https://www.riss.kr/link?id=A101596732

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objectives. Mesenchymal stem cells (MSCs) play an important role in the development and growth of tumor cells. However,the effect of human MSCs on the growth of human tumors is not well understood. The purpose of this study is to confirm the growth ef...

      Objectives. Mesenchymal stem cells (MSCs) play an important role in the development and growth of tumor cells. However,the effect of human MSCs on the growth of human tumors is not well understood. The purpose of this study is to confirm the growth effect of palatine tonsil-derived MSCs (TD-MSCs) on head and neck squamous cell carcinoma (HNSCC) cell lines and to elucidate the mechanism of their action.
      Methods. TD-MSCs were isolated from patient with chronic tonsillitis and tonsillar hypertrophy. Two human HNSCC cell lines (PNUH-12 and SNU-899) were studied and cocultured with isolated palatine tonsil-derived MSC. The growth inhibitory effect of MSCs on HNSCC cell lines was tested through methylthiazolyldiphenyl-tetrazolium (MTT) assay.
      The apoptosis induction effect of MSCs on cell lines was assessed with flow cytometry and reverse transcriptase (RT)-PCR.
      Results. Palatine tonsil-derived MSCs exhibited a growth inhibitory effect on both cell lines. Cell cycle analysis showed an accumulation of tumor cells predominantly in G0/G1 phase with an increase in concentration of TD-MSCs, which was confirmed by increased mRNA expression of cell cycle negative regulator p21. Apoptosis of tumor cells increased significantly as concentration of cocultured TD-MSCs increased. Additionally, mRNA expression of caspase 3 was upregulated with increased concentration of TD-MSCs.
      Conclusion. TD-MSCs have a potential growth inhibitory effect on HNSCC cell lines in vitro by inducing apoptotic cell death and G1 phase arrest of cell lines.

      더보기

      참고문헌 (Reference)

      1 Young RG, "Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair" 16 (16): 406-413, 1998

      2 Djouad F, "Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells" 6 : 1304-1315, 2005

      3 Lu YR, "The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo" 7 (7): 245-251, 2008

      4 Rubinstein P, "Stored placental blood for unrelated bone marrow reconstitution" 81 (81): 1679-1690, 1993

      5 Ivanovski S, "Stem cells in the periodontal ligament" 12 (12): 358-363, 2006

      6 Mapara KY, "Stem cells as vehicles for the treatment of brain cancer" 18 (18): 71-80, 2007

      7 Ehtesham M, "Stem cell therapies for malignant glioma" 19 (19): 5-, 2005

      8 Singh G, "Sources of neuronal material for implantation" 21 (21): 110-114, 2001

      9 Wakitani S, "Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine" 18 (18): 1417-1426, 1995

      10 De Bari C, "Multipotent mesenchymal stem cells from adult human synovial membrane" 44 (44): 1928-1942, 2001

      1 Young RG, "Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair" 16 (16): 406-413, 1998

      2 Djouad F, "Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells" 6 : 1304-1315, 2005

      3 Lu YR, "The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo" 7 (7): 245-251, 2008

      4 Rubinstein P, "Stored placental blood for unrelated bone marrow reconstitution" 81 (81): 1679-1690, 1993

      5 Ivanovski S, "Stem cells in the periodontal ligament" 12 (12): 358-363, 2006

      6 Mapara KY, "Stem cells as vehicles for the treatment of brain cancer" 18 (18): 71-80, 2007

      7 Ehtesham M, "Stem cell therapies for malignant glioma" 19 (19): 5-, 2005

      8 Singh G, "Sources of neuronal material for implantation" 21 (21): 110-114, 2001

      9 Wakitani S, "Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine" 18 (18): 1417-1426, 1995

      10 De Bari C, "Multipotent mesenchymal stem cells from adult human synovial membrane" 44 (44): 1928-1942, 2001

      11 Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells" 284 (284): 143-147, 1999

      12 Noth U, "Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells" 20 (20): 1060-1069, 2002

      13 Zuk PA, "Multilineage cells from human adipose tissue: implications for cell-based therapies" 7 (7): 211-228, 2001

      14 Krause DS, "Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell" 105 (105): 369-377, 2001

      15 Ramasamy R, "Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth" 21 (21): 304-310, 2007

      16 Zhu W, "Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo" 80 (80): 267-274, 2006

      17 Hamada H, "Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy" 96 (96): 149-156, 2005

      18 Caplan AI, "Mesenchymal stem cells" 9 (9): 641-650, 1991

      19 Owen M., "Marrow stromal stem cells" 10 : 63-76, 1988

      20 Lee OK, "Isolation of multipotent mesenchymal stem cells from umbilical cord blood" 103 (103): 1669-1675, 2004

      21 Yen BL, "Isolation of multipotent cells from human term placenta" 23 (23): 3-9, 2005

      22 Rzhaninova AA, "Isolation and phenotypical characterization of mesenchymal stem cells from human fetal thymus" 139 (139): 134-140, 2005

      23 Shih DT, "Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue" 23 (23): 1012-1020, 2005

      24 Sarugaser R, "Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors" 23 (23): 220-229, 2005

      25 Khakoo AY, "Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma" 203 (203): 1235-1247, 2006

      26 Nakamizo A, "Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas" 65 (65): 3307-3318, 2005

      27 Sasser AK, "Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments" 254 (254): 255-264, 2007

      28 Friedenstein AJ, "Heterotopic of bone marrow: analysis of precursor cells for osteogenic and hematopoietic tissues" 6 (6): 230-247, 1968

      29 Ku JL, "Establishment and characterization of human laryngeal squamous cell carcinoma cell lines" 109 (109): 976-982, 1999

      30 Dennis JE, "Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse" 167 (167): 523-538, 1996

      31 Byung-Joo Lee, "Change of the Expression of Human Telomerase Reverse TranscriptasemRNA and Human Telomerase RNA after Cisplatin and 5-FluorouracilExposure in Head and Neck Squamous Cell Carcinoma Cell Lines" 대한의학회 22 (22): 73-78, 2007

      32 Lee HJ, "Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model" 25 (25): 1204-1212, 200705

      33 Friedenstein AJ, "Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers" 20 (20): 263-272, 1987

      34 Elzaouk L, "Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model" 15 (15): 865-874, 2006

      35 Sekiya I, "Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs)" 19 (19): 256-264, 2004

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      학술지등록 한글명 : Clinical and Experimental Otorhinolaryngology
      외국어명 : Clinical and Experimental Otorhinolaryngology
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-10-01 평가 등재학술지 선정 (기타) KCI등재
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2009-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2007-06-14 학회명변경 영문명 : Korean Society Of Otolaryngology -> Korean Society of Otorhinolaryngology-Head and Neck Surgery
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.14 0.1 0.84
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.71 0.6 0.324 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼